Jing Luo

A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, αVβ3/αVβ5 and MMP-2/-9

Lichun Sun, Jing Luo, L. Vienna Mackey et al. · Cancer Letters · 2006 · 62 citations

Signal Transduction, Signaling Pathway, Medicine +9

Notch1-Mediated Tumor Suppression in Cervical Cancer with the Involvement of SST Signaling and Its Application in Enhanced SSTR-Targeted Therapeutics

Laura G. Franko-Tobin, L. Vienna Mackey, Wei Huang et al. · The Oncologist · 2012 · 38 citations · Full text

Targeted Chemotherapy Using a Cytotoxic Somatostatin Conjugate to Inhibit Tumor Growth and Metastasis in Nude Mice

Lichun Sun, L. Vienna Mackey, Jing Luo et al. · Clinical medicine Oncology · 2008 · 35 citations · Full text

Inhibitory Activity, Inhibit Tumor Growth, Vivo Inhibitory Activity +15

Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer

Liming Xu, Chingyun Cheng, Minglei Kang et al. · Scientific Reports · 2017 · 35 citations · Full text

Fluzoparib increases radiation sensitivity of non-small cell lung cancer (NSCLC) cells without BRCA1/2 mutation, a novel PARP1 inhibitor undergoing clinical trials

Jing Luo, Xinchi Dai, Hua Hu et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 26 citations · Full text

Brca1/2 Mutation, Novel Parp1 Inhibitor, Medicine +7